KAMIŞLI, S. Et Al. 2018. The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.40, no.4 , 344-352.

KAMIŞLI, S., ÇİFTÇİ, O., TAŞLIDERE, A., BAŞAK TÜRKMEN, N., & Ozcan, C., (2018). The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.40, no.4, 344-352.

KAMIŞLI, SUAT Et Al. "The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model," IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.40, no.4, 344-352, 2018

KAMIŞLI, SUAT Et Al. "The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.40, no.4, pp.344-352, 2018

KAMIŞLI, S. Et Al. (2018) . "The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.40, no.4, pp.344-352.

@article{article, author={SUAT KAMIŞLI Et Al. }, title={The beneficial effects of 18 beta-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model}, journal={IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY}, year=2018, pages={344-352} }